Aristides Capital »

Celldex Therapeutics shares owned by Aristides Capital

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Aristides Capital from 13F filings

Historical chart of Aristides Capital investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Aristides Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Aristides Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $202k 8.0k 25.27

More positions owned by Aristides Capital

Tesla Put Put Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Bitcoin Trust Etf Call Call Option
Ishares Bitcoin Trust Etf Put Put Option
Rigetti Computing Put Put Option
Ionq Put Put Option
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ark Etf Tr Call Call Option
Quantum Computing Put Put Option
Alphabet Cap Stk Cl A (GOOGL)
Carvana Put Put Option
California Res Corp Com Stock (CRC)
Ituran Location And Control SHS (ITRN)
D-wave Quantum Put Put Option
Strategy Put Put Option

View all positions for Aristides Capital

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics